Mar. Drugs 2009, 7(1), 24-44; doi:10.3390/md7010024

Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in China

1 Institute of Tropical Bioscience and Biotechnology, Chinese Academy of Tropical Agriculture Sciences, Haikou 571101, P.R.China 2 National Center for Drug Screening, Shanghai Institute of Materia Medica, Shanghai 201203, China 3 Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, P.R. China 4 University of Newcastle, Newcastle upon Tyne NE1 7RU, UK 5 Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100081, P.R. China
* Author to whom correspondence should be addressed.
Received: 11 December 2008; in revised form: 12 January 2009 / Accepted: 21 January 2009 / Published: 3 January 2009
(This article belongs to the Special Issue Marine Drugs Studies in China)
PDF Full-text Download PDF Full-Text [542 KB, uploaded 3 February 2009 14:17 CET]
Abstract: The mangrove ecosystem is a largely unexplored source for actinomycetes with the potential to produce biologically active secondary metabolites. Consequently, we set out to isolate, characterize and screen actinomycetes from soil and plant material collected from eight mangrove sites in China. Over 2,000 actinomycetes were isolated and of these approximately 20%, 5%, and 10% inhibited the growth of Human Colon Tumor 116 cells, Candida albicans and Staphylococcus aureus, respectively, while 3% inhibited protein tyrosine phosphatase 1B (PTP1B), a protein related to diabetes. In addition, nine isolates inhibited aurora kinase A, an anti-cancer related protein, and three inhibited caspase 3, a protein related to neurodegenerative diseases. Representative bioactive isolates were characterized using genotypic and phenotypic procedures and classified to thirteen genera, notably to the genera Micromonospora and Streptomyces. Actinomycetes showing cytotoxic activity were assigned to seven genera whereas only Micromonospora and Streptomyces strains showed anti-PTP1B activity. We conclude that actinomycetes isolated from mangrove habitats are a potentially rich source for the discovery of anti-infection and anti-tumor compounds, and of agents for treating neurodegenerative diseases and diabetes.
Keywords: Mangroves; actinomycete diversity; marine drug discovery; high-throughput screening; growth inhibition; protein tyrosine phosphatase 1B; aurora kinase A; caspase


Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Hong, K.; Gao, A.-H.; Xie, Q.-Y.; Gao, H.G.; Zhuang, L.; Lin, H.-P.; Yu, H.-P.; Li, J.; Yao, X.-S.; Goodfellow, M.; Ruan, J.-S. Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in China. Mar. Drugs 2009, 7, 24-44.

AMA Style

Hong K, Gao A-H, Xie Q-Y, Gao HG, Zhuang L, Lin H-P, Yu H-P, Li J, Yao X-S, Goodfellow M, Ruan J-S. Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in China. Marine Drugs. 2009; 7(1):24-44.

Chicago/Turabian Style

Hong, Kui; Gao, An-Hui; Xie, Qing-Yi; Gao, Hao Gao; Zhuang, Ling; Lin, Hai-Peng; Yu, Hai-Ping; Li, Jia; Yao, Xin-Sheng; Goodfellow, Michael; Ruan, Ji-Sheng. 2009. "Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in China." Mar. Drugs 7, no. 1: 24-44.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert